| scholarly article | Q13442814 |
| P2093 | author name string | R. N. Kalaria | |
| S. I. Harik | |||
| P2860 | cites work | Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein | Q29547803 |
| Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood-brain barrier monoamine oxidase activity | Q34625772 | ||
| Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity | Q37577834 | ||
| An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease | Q39462043 | ||
| Effect of aging on the blood-brain barrier | Q39645819 | ||
| Immuno-electron microscopic localization of immunoglobulins in amyloid fibrils of senile plaques | Q41982458 | ||
| The protective influence of the locus ceruleus on the blood-brain barrier | Q42256570 | ||
| Regional cerebral glucose transport and utilization in Alzheimer's disease | Q44301133 | ||
| Examination of blood-brain barrier permeability in dementia of the Alzheimer type with [68Ga]EDTA and positron emission tomography | Q44529786 | ||
| Brain microvessels are innervated by locus ceruleus noradrenergic neurons | Q45098960 | ||
| Adenosine receptors and the nucleoside transporter in human brain vasculature | Q48117222 | ||
| Blood-brain barrier monoamine oxidase: enzyme characterization in cerebral microvessels and other tissues from six mammalian species, including human | Q48217122 | ||
| Positron emission tomography in Alzheimer's disease | Q48328045 | ||
| Distribution of the glucose transporter in the mammalian brain | Q48345092 | ||
| Specific ouabain binding to brain microvessels and choroid plexus | Q48518168 | ||
| Alzheimer's disease: focal cortical changes shown by positron emission tomography | Q48768559 | ||
| Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose | Q48768629 | ||
| Diminished glucose transport in Alzheimer's disease: dynamic PET studies | Q48783668 | ||
| Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study | Q49090173 | ||
| Evidence for Blood-Brain Barrier Changes in Senile Dementia of the Alzheimer Type (SDAT) | Q49116341 | ||
| Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography | Q49147166 | ||
| On causative theories in Alzheimer's disease. | Q53191577 | ||
| Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. | Q53301872 | ||
| Increased alpha 2- and beta 2-adrenergic receptors in cerebral microvessels in Alzheimer disease | Q69360329 | ||
| Adrenergic and Cholinergic Receptors of Cerebral Microvessels | Q71067146 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| blood–brain barrier | Q221694 | ||
| cerebral circulation | Q886843 | ||
| history and philosophy of science | Q5774812 | ||
| Blood-Brain Barrier | Q70663706 | ||
| P1104 | number of pages | 6 | |
| P304 | page(s) | 47-52 | |
| P577 | publication date | 1991-01-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Blood-Brain Barrier Abnormalities in Alzheimer's Diseasea | |
| P478 | volume | 640 |
| Q34646469 | Ammonia and Alzheimer's disease |
| Q43681707 | Amplification of blood-brain barrier GLUT1 glucose transporter gene expression by brain-derived peptides |
| Q58729492 | Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and Chemokines |
| Q37216153 | Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. |
| Q48268733 | Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease. |
| Q37417409 | Breaching the blood-brain barrier as a gate to psychiatric disorder |
| Q39012005 | Glucose Transporters in Brain: In Health and in Alzheimer's Disease |
| Q33938994 | Mouse models of neurological disorders: a view from the blood-brain barrier |
| Q41954486 | Piracetam and TRH analogues antagonise inhibition by barbiturates, diazepam, melatonin and galanin of human erythrocyte D-glucose transport. |
| Q34409691 | Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response |
| Q44283281 | Regional differences in PACAP transport across the blood-brain barrier in mice: a possible influence of strain, amyloid beta protein, and age. |
| Q48818877 | Regional transport of TNF-alpha across the blood-brain barrier in young ICR and young and aged SAMP8 mice |
| Q46305128 | Vascular volume and blood-brain barrier permeability measured by dynamic contrast enhanced MRI in hippocampus and cerebellum of patients with MCI and normal controls |
Search more.